The University of Chicago Header Logo

Connection

Daniel Wilson to Spironolactone

Back to Details
This is a "connection" page, showing publications Daniel Wilson has written about Spironolactone.
Daniel Wilson
Connection Strength
0.189
Spironolactone
  1. Finerenone: a mineralocorticoid receptor antagonist for the treatment of chronic kidney disease associated with type 2 diabetes. Expert Rev Clin Pharmacol. 2022 May; 15(5):501-513.
    View in: PubMed
    Score: 0.189
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.